Device for transdermal electrotransport delivery of fentanyl and sufentanil
US7018370B2 · kind B2 · utility
36Cited by
23References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 2, 2002 |
| Grant date | Mar 28, 2006 |
| Priority date | — |
| Expiry date | Sep 27, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N1/0448
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides an improved electrotransport drug delivery system for analgesic drugs, namely fentanyl and sufentanil. The fentanyl/sufentanil is provided as a water soluble salt (e.g., fentanyl hydrochloride), preferably in a hydrogel formulation, for use in an electrotransport device (10). In accordance with the present invention, a transdermal electrotransport delivered dose of fentanyl/sufentanil is provided which is sufficient to induce analgesia in (e.g., adult) human patients suffering from moderate-to-severe pain associated with major surgical procedures.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.